148 results on '"Dasgupta, Subhamoy"'
Search Results
2. Protocol to detect and quantify tumor hypoxia in mice using photoacoustic imaging
3. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.
4. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes.
5. Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs
6. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
7. High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma
8. TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer
9. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis
10. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
11. Supplementary Data from Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis
12. Data from Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis
13. Supplementary Methods from Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone
14. Data from Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone
15. Supplementary Figures from Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone
16. Data from HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes
17. Supplementary Data 1 from HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes
18. Supplementary Data 2 from HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes
19. Supplementary Figures 1 through 10 and Supplementary Tables 1 and 2 from HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes
20. SRC-2 orchestrates polygenic inputs for fine-tuning glucose homeostasis
21. Abstract A017: Bidirectional signaling between mitochondria and the nucleus dictates epigenetic rewiring to drive tumorigenesis
22. Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence
23. Regulation of tumor metabolism by post translational modifications on metabolic enzymes
24. SRC-2 Is an Essential Coactivator for Orchestrating Metabolism and Circadian Rhythm
25. Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis
26. Abstract P5-06-12: Extracellular adenosine synthesis genes regulated by estrogen signaling are associated with cancer aggressiveness and poor prognosis in estrogen receptor (ER)-positive breast cancer
27. Hypoxic Tumor Microenvironment Induces Metabolic Enzyme PFKFB4 Acquiring Invasive Cancer Phenotype to Drive Metastasis
28. Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer
29. Abstract 2798: CD73 suppresses anti-cancer immunity and promotes glycolysis, resulting in poor prognosis in pancreatic ductal adenocarcinoma
30. Abstract PO022: Metabolic and transcriptional adaptations under hypoxic stress promote breast cancer progression
31. Transcriptional repression of SIRT3 potentiates mitochondrial aconitase activation to drive aggressive prostate cancer to the bone
32. Abstract 4706: Transcriptional repression of mitochondrial deacetylase SIRT3 promotes prostate cancer metastasis
33. High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
34. Abstract 5200: High CD73 expression, regulated by estrogen signaling, associates with cancer aggressiveness in estrogen receptor (+) breast cancer
35. Metabolic Dysregulation Controls Endocrine Therapy–Resistant Cancer Recurrence and Metastasis
36. Novel gene C17orf37 in Prostate Cancer Progression and Metastasis: A Prospective Biomarker
37. Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
38. Abstract 1084: TRAF4-mediated NGF receptor TrkA ubiquitination regulates prostate cancer metastasis
39. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells
40. Abstract 1056: Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer
41. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
42. Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading
43. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression
44. MIEN1 promotes oral cancer progression and implicates poor overall survival
45. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
46. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1
47. Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology
48. Nuclear Receptor Coactivators: Master Regulators of Human Health and Disease
49. Novel gene C17orf37 in Prostate Cancer Progression and Metastasis: A Prospective Biomarker
50. Abstract 5153: Steroid receptor coactivator-2 mediates oncogenic reprogramming of cancer cell metabolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.